Marc Ribo

Dr Marc Ribo
Editor

Assistant Professor Stroke Unit. Department of Neurology; Neurologist. Hospital Vall d’Hebron. Barcelona

Education/Training

1998: Universitat de Barcelona, Spain (MD)

2003: Hospital Vall d’Hebron/ Univ Autonoma Barcelona (Residency) Neurology

2003: Hospital Vall d’Hebron Barcelona, Spain (Stroke Fellowship) Stroke/Cerebrovascular Ultrasound Medicine

2004: Universitat Autonoma Barcelona (Ph.D.) Medicine

2004-05: University Of Texas-Houston, Stroke Program (Vascular Neurology fellowship) Stroke

Research & Professional Experience

Professional experience

1999-2003: Neurology Resident

2003-2004: Postgraduate Research Fellow, Neurovascular Unit, Vall d’Hebron. Barcelona Spain

2004: Carotid & cerebral angiography assistant. Neuroradiology, UD Platon Barcelona

2003-2004: Neurologist. Stroke Unit, Vall d’Hebron Hospital Barcelona

2004-2005: Vascular Neurology Fellowship, Stroke Program Department of Neurology, University of Texas-Houston

2006- : Neurology Staff, Stroke Neurologist and Interventionalist. Department of Neurology. Hospital Vall d’Hebron. Barcelona.

2013: Board of directors Member Society of Vascual Interventional Neurology

2014: Member of European Society of Minimally Invasive Neurological Therapy

Certifications

1998: Medical Doctor. Universitat de Barcelona, Spain

2003: Neurologist. Ministerio de Sanidad y Consumo. Spain

2004: Clinical/Research Fellowships, Stroke. Spanish society of Neurology.

2004: Ph.D. Medicine. Universitat Autonoma de Barcelona, Spain

2005: Educational Commission for Foreign Medical Graduates, USA

2005: Vascular Neurology Fellowship, University of Texas-Houston.

Awards / Grants

2003 -   Prize award. European Stroke Conference 2003 (co-author)

2003    -    Stroke Fellowship Grant, Spanish Society of Neurology

2004    -    Prize award. European Stroke Conference 2004 (co-author)

2004    -    Clinical Research Grant from “Fundacion Mutua Madrilena Automovilista”, Spain

2009-2013: Grant: Beca FIS Instituto de Salud Carlos III Nº PI09/01660. Spanish Ministry of Health. PI: Marc Ribó
Neuroprotección mediante sistema de perfusión artificial de la penumbra isquémcia con sangre arterial oxigenada

2006-2009: Grant: Beca FIS Instituto de Salud Carlos III Nº PI06/0586. PI: Marc Ribó
Geno-tPA: Búsqueda de patrones genéticos predictivos de la evolución del paciente con ictus isquémico después del tratamiento con t-PA”.

2007-2009: Grant: Beca FIS Instituto de Salud Carlos III Nº PS07/90607. Spanish ministry of health. PI: Marc Ribó
EVALUACIÓN DE LA SEGURIDAD Y EFICACIA DE UN SISTEMA DE TELEMEDICINA PARA LA VALORACIÓN URGENTE Y TRATAMIENTO DE PACIENTES CON ENFERMEDAD VASCULAR CEREBRAL AGUDA EN ÁREAS RURALES”

2013: Grant: Fundación Vodafone Spain. Global TeleRehabilitation system for stroke patients. PI: Marc Ribó

2013-2016: Grant: Beca FIS Instituto de Salud Carlos III Nº PI13/02508. Spanish ministry of health. PI: Marc Ribó. Modificación saludable del estilo de vida y monitorización de tratamiento en prevención secundaria del ictus mediante plataforma digital para dispositivo móvil

Teaching Experience in Cerebrovascular diseases and Ultrasound

Universitat Autonoma Barcelona: Lectures, Neurovascular Courses, and Ultrasound, Hospital Vall d’Hebron, Spain:2000-2014

Reviewer for Journals

  • The Lancet Neurology
  • Stroke
  • Blood Coagulation and Fibrinolysis. International Journal of thrombosis and haemostasis
  • European Journal of Neurology
  • Thrombosis & Haemostasis
  • Journal of Neurology, Neurosurgery, and Psychiatry    
  • Journal of Neurointerventional Surgery
  • Plos one
  • Journal of Neuroimaging
  • Interventional Neurology
  • Neurologia. The official journal of the Spanish Society of Neurology.

Doctoral Thesis Director

Universitat Autónoma de Barcelona. 2010. Jorge Pagola. Basilar artery thrombosis, ischemic tolerance, response to sonothrombolysis and hemorrhagic transformation.

Universitat Autónoma de Barcelona. 2014. Alan Flores. Prognositc factors in acute stroke patients treatred with endovascular procedures

Universitat Autónoma de Barcelona. 2015. Angels Pedragosa. Impact of Telemedicine systems in the acute treatment of ischemic stroke patients in Community Hospitals.

Selected Original Papers

(>140 papers published in peer reviewed journals. PubMed): www.ncbi.nlm.nih.gov/pubmed/?term=Ribo+M.+Stroke

Most recent:

  1. Flores A, Rubiera M, Ribó M, Pagola J, Rodriguez-Luna D, Muchada M, Boned S, Seró L, Sanjuan E, Meler P, Carcámo D, Santamarina E, Tomassello A, Lemus M, Coscojuela P, Molina CA. Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies. Stroke. 2015 Sep 29. pii: STROKEAHA.115.010608. [Epub ahead of print] PubMed PMID: 26419969.
  2. Ribo M, Tomasello A, Lemus M, Rubiera M, Vert C, Flores A, Coscojuela P, Pagola J, Rodriguez-Luna D, Bonet S, Muchada M, Rovira A, Molina CA. Maximal Admission Core Lesion Compatible With Favorable Outcome in Acute Stroke Patients Undergoing Endovascular Procedures. Stroke. 2015 Oct;46(10):2849-52. doi: 10.1161/STROKEAHA.115.010707. Epub 2015 Aug 20. PubMed PMID: 26294674.
  3. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015 Jun 11;372(24):2296-306. doi: 10.1056/NEJMoa1503780. Epub 2015 Apr 17. PubMed PMID: 25882510.
  4. Merino-Zamorano C, Hernández-Guillamon M, Jullienne A, Le Béhot A, Bardou I, Parés M, Fernández-Cadenas I, Giralt D, Carrera C, Ribó M, Vivien D, Ali C, Rosell A, Montaner J. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke. Stroke. 2015 Feb;46(2):477-84. doi: 10.1161/STROKEAHA.114.006826. Epub 2014 Dec 11. PubMed PMID: 25503547.
  5. Urra X, San Román L, Gil F, Millán M, Cánovas D, Roquer J, Cardona P, Ribó M, Martí-Fàbregas J, Abilleira S, Chamorro Á; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR). Medical and endovascular treatment of patients with large vessel occlusion presenting with mild symptoms: an observational multicenter study. Cerebrovasc Dis. 2014;38(6):418-24. doi: 10.1159/000369121. Epub 2014 Dec 3. PubMed PMID: 25472576.
  6. Abilleira S, Ribera A, Dávalos A, Ribó M, Chamorro A, Cardona P, Molina CA, Martínez-Yélamos A, Urra X, Dorado L, Roquer J, Martí-Fàbregas J, Aja L, Tomasello A, Castaño C, Blasco J, Cánovas D, Castellanos M, Krupinski J, Guimaraens L, Perendreu J, Ustrell X, Purroy F, Gómez-Choco M, Baiges JJ, Cocho D, Saura J, Gallofré M; Catalan Stroke Code and Reperfusion Consortium. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study. Cerebrovasc Dis. 2014;38(5):328-36. doi: 10.1159/000368433. Epub 2014 Nov 21. PubMed PMID: 25428822.
  7. Rangaraju S, Aghaebrahim A, Streib C, Sun CH, Ribo M, Muchada M, Nogueira R, Frankel M, Gupta R, Jadhav A, Jovin TG. Pittsburgh Response to Endovascular therapy (PRE) score: optimizing patient selection for endovascular therapy for large vessel occlusion strokes. J Neurointerv Surg. 2015 Nov;7(11):783-8. doi: 10.1136/neurintsurg-2014-011351. Epub 2014 Oct 15. PubMed PMID: 25320054.
  8. Rodriguez-Luna D, Muchada M, Piñeiro S, Flores A, Rubiera M, Pagola J, Coscojuela P, Meler P, Sanjuan E, Boned-Riera S, Cárcamo DA, Tomasello A, Alvarez-Sabin J, Ribo M, Molina CA. Potential blood pressure thresholds and outcome in acute intracerebral hemorrhage. Eur Neurol. 2014;72(3-4):203-8. doi: 10.1159/000362269. Epub 2014 Sep 13. PubMed PMID: 25287269.
  9. Muchada M, Rodriguez-Luna D, Pagola J, Flores A, Sanjuan E, Meler P, Boned S, Alvarez-Sabin J, Ribo M, Molina CA, Rubiera M. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2014 Sep;45(9):2734-8. doi: 10.1161/STROKEAHA.114.006222. Epub 2014 Aug 7. PubMed PMID: 25104845.
  10. Pagola J, González-Alujas T, Muchada M, Teixidó G, Flores A, De Blauwe S, Seró L, Luna DR, Rubiera M, Ribó M, Boned S, Álvarez-Sabin J, Evangelista A, Molina CA. Stroke echoscan protocol: a fast and accurate pathway to diagnose embolic strokes. J Neuroimaging. 2015 May-Jun;25(3):365-9. doi: 10.1111/jon.12139. Epub 2014 Jul 15. PubMed PMID: 25040029.
  11. Pagola J, González-Alujas T, Flores A, Muchada M, Rodriguez-Luna D, Seró L, Rubiera M, Boned S, Ribó M, Alvarez-Sabin J, Evangelista A, Molina CA. Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes. Stroke. 2014 Aug;45(8):e164-6. doi: 10.1161/STROKEAHA.114.005540. Epub 2014 Jun 26. PubMed PMID: 24968931.
  12. Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, Hill MD, Jovin TG, Ribo M, Yan B, Zaidat OO, Frei D, von Kummer R, Cockroft KM, Khatri P, Liebeskind DS, Tomsick TA, Palesch YY, Broderick JP; IMS III Investigators. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014 Oct;273(1):202-10. doi: 10.1148/radiol.14132649. Epub 2014 Jun 5. PubMed PMID: 24895878; PubMed Central PMCID: PMC4174723.
  13. Sun CH, Ribo M, Goyal M, Yoo AJ, Jovin T, Cronin CA, Zaidat O, Nogueira R, Nguyen T, Hussain S, Menon BK, Mehta B, Jindal G, Horev A, Norbash A, Leslie-Mazwi T, Wisco D, Gupta R. Door-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc. 2014;3(2):e000859. PubMed PMID: 24772523; PubMed Central PMCID: PMC4187502.
  14. Flores A, Ribó M, Rubiera M, Gonzalez-Cuevas M, Pagola J, Rodriguez-Luna D, Muchada M, Kallas J, Meler P, Sanjuan E, Alvarez-Sabin J, Montaner J, Molina CA. Monitoring of cortical activity postreperfusion. A powerful tool for predicting clinical response immediately after recanalization. J Neuroimaging. 2015 Mar-Apr;25(2):257-62. doi: 10.1111/jon.12113. Epub 2014 Mar 19. PubMed PMID: 24641595.
  15. Muchada M, Rubiera M, Rodriguez-Luna D, Pagola J, Flores A, Kallas J, Sanjuan E, Meler P, Alvarez-Sabin J, Ribo M, Molina CA. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke. Stroke. 2014 Apr;45(4):1059-63. doi: 10.1161/STROKEAHA.113.004307. Epub 2014 Mar 6. PubMed PMID: 24603070.
  16. Abilleira S, Cardona P, Ribó M, Millán M, Obach V, Roquer J, Cánovas D, Martí-Fàbregas J, Rubio F, Alvarez-Sabín J, Dávalos A, Chamorro A, de Miquel MA, Tomasello A, Castaño C, Macho JM, Ribera A, Gallofré M; Catalan Stroke Code and Reperfusion Consortium. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy. Stroke. 2014 Apr;45(4):1046-52. doi: 10.1161/STROKEAHA.113.003489. Epub 2014 Mar 4. PubMed PMID: 24595590.
  17. Flores A, Tomasello A, Cardona P, de Miquel MA, Gomis M, Garcia Bermejo P, Obach V, Urra X, Martí-Fàbregas J, Cánovas D, Roquer J, Abilleira S, Ribó M; Catalan Stroke Code and Reperfusion Consortium Cat-SCR. Endovascular treatment for M2 occlusions in the era of stentrievers: a descriptive multicenter experience. J Neurointerv Surg. 2015 Apr;7(4):234-7. doi: 10.1136/neurintsurg-2014-011100. Epub 2014 Feb 27. PubMed PMID: 24578483.
  18. Massot A, Giralt D, Penalba A, Garcia-Berrocoso T, Navarro-Sobrino M, Arenillas JF, Ribó M, Molina CA, Alvarez-Sabín J, Montaner J, Delgado P. Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence. Atherosclerosis. 2014 Mar;233(1):186-9. doi: 10.1016/j.atherosclerosis.2013.12.034. Epub 2014 Jan 8. PubMed PMID: 24529142.
  19. Llombart V, Dominguez C, Bustamante A, Rodriguez-Sureda V, Martín-Gallán P, Vilches A, García-Berrocoso T, Penalba A, Hernández-Guillamon M, Rubiera M, Ribó M, Eschenfelder C, Giralt D, Molina CA, Alvarez-Sabín J, Rosell A, Montaner J. Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis. Stroke. 2014 Feb;45(2):432-7. doi: 10.1161/STROKEAHA.113.003431. Epub 2013 Dec 12. PubMed PMID: 24335228.
  20. Jadhav AP, Ribo M, Grandhi R, Linares G, Aghaebrahim A, Jovin TG, Jankowitz BT. Transcervical access in acute ischemic stroke. J Neurointerv Surg. 2014 Nov;6(9):652-7. doi: 10.1136/neurintsurg-2013-010971. Epub 2013 Nov 7. PubMed PMID: 24203916.
  21. Ribo M, Flores A, Mansilla E, Rubiera M, Tomasello A, Coscojuela P, Pagola J, Rodriguez-Luna D, Muchada M, Alvarez-Sabín J, Molina CA. Age-adjusted infarct volume threshold for good outcome after endovascular treatment. J Neurointerv Surg. 2014 Jul;6(6):418-22. doi: 10.1136/neurintsurg-2013-010786. Epub 2013 Jul 6. PubMed PMID: 23832414.
  22. Pagola J, Rubiera M, Flores A, Rodríguez-Luna D, Piñeiro S, Muchada MA, Quintana M, Alvarez-Sabin J, Molina CA, Ribo M. Selecting endovascular treatment strategy according to the location of intracranial occlusion in acute stroke. Cerebrovasc Dis. 2013;35(6):502-6. doi: 10.1159/000350198. Epub 2013 Jun 6. PubMed PMID: 23751728.
  23. Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, Labreuche J, Meseguer E, Yeatts SD, Siddiqui AH, Broderick J, Molina CA, Qureshi AI, Amarenco P. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 2013 May 14;127(19):1980-5. doi: 10.1161/CIRCULATIONAHA.112.000311. PubMed PMID: 23671178.
  24. Rodriguez-Luna D, Piñeiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J, Flores A, Muchada M, Ibarra B, Meler P, Sanjuan E, Hernandez-Guillamon M, Alvarez-Sabin J, Montaner J, Molina CA. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013 Sep;20(9):1277-83. doi: 10.1111/ene.12180. Epub 2013 May 5. PubMed PMID: 23647568.
  25. Fernandez-Cadenas I, Del Rio-Espinola A, Domingues-Montanari S, Mendioroz M, Fernandez-Morales J, Penalba A, Rubiera M, Hernandez-Guillamon M, Rosell A, Delgado P, Chacon P, Ribo M, Alvarez-Sabin J, Molina CA, García-Arumi E, Montaner J. Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patients. Pharmacogenomics. 2013 Apr;14(5):495-504. doi: 10.2217/pgs.13.19. PubMed PMID: 23556447.
  26. Massot A, Navarro-Sobrino M, Penalba A, Arenillas JF, Giralt D, Ribó M, Molina CA, Alvarez-Sabín J, Montaner J, Rosell A. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts. Cerebrovasc Dis. 2013;35(1):81-8. doi: 10.1159/000346097. Epub 2013 Feb 14. PubMed PMID: 23429001.
  27. Alvarez-Sabín J, Ortega G, Jacas C, Santamarina E, Maisterra O, Ribo M, Molina C, Quintana M, Román GC. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis. 2013;35(2):146-54. doi: 10.1159/000346602. Epub 2013 Feb 7. PubMed PMID: 23406981.
  28. Tsivgoulis G, Ribo M, Rubiera M, Vasdekis SN, Barlinn K, Athanasiadis D, Bavarsad Shahripour R, Giannopoulos S, Stamboulis E, Harrigan MR, Molina CA, Alexandrov AV. Real-time validation of transcranial Doppler criteria in assessing recanalization during intra-arterial procedures for acute ischemic stroke: an international, multicenter study. Stroke. 2013 Feb;44(2):394-400. doi: 10.1161/STROKEAHA.112.675074. Epub 2013 Jan 10. PubMed PMID: 23306320.
  29. del Río-Espínola A, Fernández-Cadenas I, Giralt D, Quiroga A, Gutiérrez-Agulló M, Quintana M, Fernández-Álvarez P, Domingues-Montanari S, Mendióroz M, Delgado P, Turck N, Ruíz A, Ribó M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Cuadrado-Godia E, Roquer J, Chacón P, Martí-Fábregas J, Sánchez JC; GRECOS Investigators, Montaner J. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke. Ann Neurol. 2012 Nov;72(5):716-29. doi: 10.1002/ana.23664. PubMed PMID: 23280790.
  30. Pedragosa A, Alvarez-Sabín J, Rubiera M, Rodriguez-Luna D, Maisterra O, Molina C, Brugués J, Ribó M. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures. Cerebrovasc Dis. 2012;34(5-6):436-42. doi: 10.1159/000345088. Epub 2012 Dec 1. PubMed PMID: 23207552.
  31. Ribo M, Flores A, Rubiera M, Pagola J, Mendonca N, Rodriguez-Luna D, Piñeiro S, Meler P, Alvarez-Sabin J, Molina CA. Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome. J Neurointerv Surg. 2013 May;5 Suppl 1:i70-3. doi: 10.1136/neurintsurg-2012-010438. Epub 2012 Oct 31. PubMed PMID: 23117130.
  32. Vivancos J, Gilo F, Frutos R, Maestre J, García-Pastor A, Quintana F, Roda JM, Ximénez-Carrillo A; por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN:, Díez Tejedor E, Fuentes B, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, Fernández JC, Freijo M, Gállego J, Gil-Núñez A, Irimia P, Lago A, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Morales A, Nombela F, Purroy F, Ribó M, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia. 2014 Jul-Aug;29(6):353-70. doi: 10.1016/j.nrl.2012.07.009. Epub 2012 Oct 6. English, Spanish. PubMed PMID: 23044408.
  33. Montaner J, García-Berrocoso T, Mendioroz M, Palacios M, Perea-Gainza M, Delgado P, Rosell A, Slevin M, Ribó M, Molina CA, Alvarez-Sabín J. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Cerebrovasc Dis. 2012;34(3):240-5. doi: 10.1159/000341858. Epub 2012 Sep 26. PubMed PMID: 23018289.
  34. Mendonça N, Flores A, Pagola J, Rubiera M, Rodríguez-Luna D, De Miquel MA, Cardona P, Quesada H, Mora P, Alvarez-Sabín J, Molina C, Ribó M. Trevo versus solitaire a head-to-head comparison between two heavy weights of clot retrieval. J Neuroimaging. 2014 Mar-Apr;24(2):167-70. doi: 10.1111/j.1552-6569.2012.00730.x. Epub 2012 Aug 22. PubMed PMID: 22913726.
  35. Sargento-Freitas J, Pagola J, Rubiera M, Flores A, Silva F, Rodriguez-Luna D, Pineiro S, Alvarez-Sabín J, Molina CA, Ribo M. Preferential effect of premorbid statins on atherothrombotic strokes through collateral circulation enhancement. Eur Neurol. 2012;68(3):171-6. Epub 2012 Aug 14. PubMed PMID: 22906913.
  36. Fernández-Cadenas I, Del Río-Espínola A, Giralt D, Domingues-Montanari S, Quiroga A, Mendióroz M, Ruíz A, Ribó M, Serena J, Obach V, Freijo MM, Martí-Fábregas J, Delgado P, Montaner J. IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke. Stroke. 2012 Oct;43(10):2659-65. Epub 2012 Aug 2. PubMed PMID: 22858724.
  37. Santamarina E, Penalba A, García-Berrocoso T, Delgado P, Quintana M, González-Alujas T, Ribó M, Maisterra O, Molina CA, Evangelista A, Alvarez-Sabín J, Montaner J. Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol. 2012 Dec;259(12):2538-45. doi: 10.1007/s00415-012-6532-4. Epub 2012 May 17. PubMed PMID: 22592287.
  38. Fernández-Cadenas I, Del Río-Espínola A, Carrera C, Domingues-Montanari S, Mendióroz M, Delgado P, Rosell A, Ribó M, Giralt D, Quintana M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Roquer J, Martí-Fábregas J, Molina CA, Alvarez-Sabín J, Montaner J. Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients. Stroke. 2012 May;43(5):1398-400. doi: 10.1161/STROKEAHA.111.639823. Epub 2012 Apr 10. PubMed PMID: 22496335.
  39. Montaner J, Mendioroz M, Delgado P, García-Berrocoso T, Giralt D, Merino C, Ribó M, Rosell A, Penalba A, Fernández-Cadenas I, Romero F, Molina C, Alvarez-Sabín J, Hernández-Guillamon M. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. J Proteomics. 2012 Aug 3;75(15):4758-65. doi: 10.1016/j.jprot.2012.01.033. Epub 2012 Feb 11. PubMed PMID: 22343074.
  40. Flores A, Sargento-Freitas J, Pagola J, Rodriguez-Luna D, Piñeiro S, Maisterra O, Rubiera M, Montaner J, Alvarez-Sabin J, Molina C, Ribo M. Arterial blood gas analysis of samples directly obtained beyond cerebral arterial occlusion during endovascular procedures predicts clinical outcome. J Neuroimaging. 2013 Apr;23(2):180-4. doi: 10.1111/j.1552-6569.2011.00667.x. Epub 2011 Dec 30. PubMed PMID: 22211838.
  41. Mendonça N, Flores A, Pagola J, Rubiera M, Rodríguez-Luna D, De Miquel MA, Cardona P, Quesada H, Mora P, Alvarez-Sabín J, Molina C, Ribó M. Trevo System: single-center experience with a novel mechanical thrombectomy device. J Neuroimaging. 2013 Jan;23(1):7-11. doi: 10.1111/j.1552-6569.2011.00666.x. Epub 2011 Dec 30. PubMed PMID: 22211809.
  42. Pedragosa A, Álvarez-Sabín J, Molina CA, Brugués J, Ribó M. [Collaboration between different links: one of the keys to the telestroke system. Reply]. Rev Neurol. 2012 Jan 1;54(1):64. Spanish. PubMed PMID: 22187216.
  43. Delgado P, Chacón P, Penalba A, Pelegri D, García-Berrocoso T, Giralt D, Santamarina E, Ribó M, Maisterra O, Alvarez-Sabín J, Rosell A, Montaner J. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovasc Dis. 2012;33(2):150-8. doi: 10.1159/000334193. Epub 2011 Dec 14. PubMed PMID: 22178747.
  44. Delgado P, Chacón P, Penalba A, Pelegrí D, Merino C, Ribó M, Rubiera M, Álvarez-Sabin J, Montaner J. Temporal profile and prognostic value of Lp-PLA2 mass and activity in the acute stroke setting. Atherosclerosis. 2012 Feb;220(2):532-6. doi: 10.1016/j.atherosclerosis.2011.11.016. Epub 2011 Nov 19. PubMed PMID: 22153151.
  45. Alonso de Leciñana M, Egido JA, Casado I, Ribó M, Dávalos A, Masjuan J, Caniego JL, Martínez Vila E, Díez Tejedor E; ad hoc committee of the SEN Study Group for Cerebrovascular Diseases, Fuentes B, Álvarez-Sabin J, Arenillas J, Calleja S, Castellanos M, Castillo J, Díaz-Otero F, López-Fernández JC, Freijo M, Gállego J, García-Pastor A, Gil-Núñez A, Gilo F, Irimia P, Lago A, Maestre J, Martí-Fábregas J, Martínez-Sánchez P, Molina C, Morales A, Nombela F, Purroy F, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J, Vivancos J; Spanish Neurological Society. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014 Mar;29(2):102-22. doi: 10.1016/j.nrl.2011.09.012. Epub 2011 Dec 6. Review. English, Spanish. PubMed PMID: 22152803.
  46. Mendonça N, Rodriguez-Luna D, Rubiera M, Boned-Riera S, Ribo M, Pagola J, Piñeiro S, Meler P, Alvarez-Sabin J, Montaner J, Molina CA. Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion. Stroke. 2012 Feb;43(2):417-21. doi: 10.1161/STROKEAHA.111.632653. Epub 2011 Dec 1. PubMed PMID: 22135072.
  47. Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Piñeiro S, Pagola J, Hernandez-Guillamon M, Ibarra B, Romero F, Alvarez-Sabin J, Montaner J, Molina CA. Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology. 2011 Oct 25;77(17):1599-604. doi: 10.1212/WNL.0b013e3182343387. Epub 2011 Oct 12. PubMed PMID: 21998314.
  48. Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovasc Dis. 2012;33(1):55-63. doi: 10.1159/000333370. Epub 2011 Dec 1. PubMed PMID: 22133888.
  49. Ribo M, Flores A, Rubiera M, Pagola J, Sargento-Freitas J, Rodriguez-Luna D, Coscojuela P, Maisterra O, Piñeiro S, Romero FJ, Alvarez-Sabin J, Molina CA. Extending the time window for endovascular procedures according to collateral pial circulation. Stroke. 2011 Dec;42(12):3465-9. doi: 10.1161/STROKEAHA.111.623827. Epub 2011 Sep 29. PubMed PMID: 21960574.
  50. Fuentes B, Gállego J, Gil-Nuñez A, Morales A, Purroy F, Roquer J, Segura T, Tejada J, Lago A, Díez-Tejedor E; por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN:, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, López-Fernández JC, Freijo M, García Pastor A, Gilo F, Irimia P, Maestre J, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Nombela F, Ribó M, Rodríguez-Yañez M, Rubio F, Serena J, Simal P, Vivancos J; Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological. Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia. 2014 Apr;29(3):168-83. doi: 10.1016/j.nrl.2011.06.003. Epub 2011 Sep 19. Review. English, Spanish. PubMed PMID: 21937151.
  51. Salvado-Figueras M, Quintana M, Ribo M, Álvarez-Sabín J. [Profile of neurovascular emergencies in a tertiary care hospital: evolution over the period 2001-2008]. Rev Neurol. 2011 Sep 16;53(6):321-8. Spanish. PubMed PMID: 21894603.

Abstracts

(total > 200 original papers presented at scientific meetings and published in 2000-2013).

Investigator in sponsored clinical trials

  1. AbEST. Abciximab in Acute Ischemic Stroke: a randomized, doble-blind, placebo-controlled trial (REOPRO).
  2. F71CH-1389. (NovoSeven®)
  3. UK-279,276: ASTIN study. (anti-MAC-1).
  4. MATCH: Management of atherothrombosis with clopidogrel in hihg-risk patient with recent transient ischemic attack or ischemic stroke.
  5. SA-NXY-0006: SAINT-1. A double blind, randomized, placebo controlled, parallel group, multicenter, phase Iib/III study to assess the efficacy and safety of intravenous NXY-059 in acute ischemic stroke.
  6. CHARISMA: Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance.
  7. AbESTT-II: Abciximab (ReoPro®) in acute ischemic stroke: A phase III, multinational, randomized, double-blind, placebo-controlled trial.
  8. CLOTBUST Trial. Combined ultrasound & tPA for acute ischemic stroke
  9. F71CH-1371: recombinant factor VII(Novoseven®) in acute intracerebral haemorrhage (ICH).
  10. ProFESS: A double-blind, active and placebo controlled study of Aggrenox® vs Clopidogrel + aspirin, with and without Micardis®.
  11. ECASS III: Ensayo controlado con placebo de Alteplasa (rt-PA) en el ictus hemisférico isquémico en el que la trombolisis da comienzo entre 3 y 4h después del comienzo del ictus.
  12. BAYx3702/100282: Repinotan for acute ischemic stroke
  13. SA-NXY-0012: intravenous infusion of  NXY-059 in adult patients with acute intracerebral hemorrhage (ICH).
  14. PERFORM Study. An international, randomized, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg
  15. Trial of activated recombinant factor VII (NovoSeven ® / Niastase) in acute intracerebral haemorrhage.
  16. SAINT II ( Stroke-Acute ischemic-NXY Treatment).
  17. SENTIS (COAXIA)
  18. ImPACT-24 (Brainsgate)
  19. DIAS-III
  20. IMS-III
  21. NEST-3 – Photothera
  22. Revascat. Endovascular treatment with Solitaire Vs Best medical Treatment in acute ischemic stroke patients.
  23. Socrates. ASA Vs Ticagrelor in TIA or minor stroke.
  24. Action. Biogen.
  25. Clotbuster
  26. DAWN

 

October 19th, 2015